Clinical trial
Rosiglitazone and Insulin in T1DM Adolescents
NCT00372086 · The University of New South Wales, Other · Completed
Key facts
| NCT number | NCT00372086 |
|---|---|
| Title | Rosiglitazone and Insulin in T1DM Adolescents |
| Official title | The Addition of Rosiglitazone to Insulin in Adolescents With Type 1 Diabetes and Poor Glycaemic Control: a Randomized, Placebo Controlled Trial |
| Lead sponsor | The University of New South Wales, Other |
| Collaborators | Sydney Children's Hospitals Network National Health and Medical Research Council, Australia Novo Nordisk A/S Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes, Puberty: >Tanner 2 Breast Development or Testis >4ml |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 32 |
| Start date | Aug 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Sep 6, 2006 |
| Last update posted | Sep 6, 2006 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: